These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35394397)

  • 41. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
    Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
    Front Immunol; 2019; 10():773. PubMed ID: 31031764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of platelet aggregation in the presence of antiphospholipid antibodies: anti-β2GP1 and anticardiolipin.
    de Mesquita HL; de Carvalho GR; Aarestrup FM; Corrêa JO; Azevedo MR
    Rev Bras Reumatol; 2013; 53(5):400-4. PubMed ID: 24316896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
    Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
    Vega-Ostertag M; Harris EN; Pierangeli SS
    Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients.
    Guerin J; Casey E; Feighery C; Jackson J
    Autoimmunity; 1999 Oct; 31(2):109-16. PubMed ID: 10680749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
    Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
    Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT
    Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome.
    Vils SR; Troldborg A; Hvas AM; Thiel S
    TH Open; 2023 Apr; 7(2):e155-e167. PubMed ID: 37333022
    [No Abstract]   [Full Text] [Related]  

  • 54. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
    Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β
    Ho YC; Ahuja KDK; Körner H; Adams MJ
    Antibodies (Basel); 2016 May; 5(2):. PubMed ID: 31557993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis.
    Bu C; Li Z; Zhang C; Gao L; Cai G
    Clin Rheumatol; 2008 Feb; 27(2):171-8. PubMed ID: 17646899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation.
    Andrianova IA; Ponomareva AA; Mordakhanova ER; Le Minh G; Daminova AG; Nevzorova TA; Rauova L; Litvinov RI; Weisel JW
    J Autoimmun; 2020 Feb; 107():102355. PubMed ID: 31732191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
    Radway-Bright EL; Ravirajan CT; Isenberg DA
    Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.